Pediapharm Inc. (CVE:PDP – Get Free Report) shares were up 1.7% on Thursday . The company traded as high as C$0.30 and last traded at C$0.30. 26,000 shares were traded during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.29.
Pediapharm Price Performance
The firm has a market capitalization of C$66.36 million and a PE ratio of -4.11. The company has a 50-day moving average price of C$0.30 and a 200-day moving average price of C$0.30. The company has a debt-to-equity ratio of 186.87, a current ratio of 1.12 and a quick ratio of 0.71.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.
See Also
- Five stocks we like better than Pediapharm
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
